Yang JS, Xu ZY, Chen FX, Wang MR, Cong RC, Fan XL, He BS, Xing W. Role of clinical data and multidetector computed tomography findings in acute superior mesenteric artery embolism. World J Clin Cases 2022; 10(13): 4020-4032 [PMID: 35665105 DOI: 10.12998/wjcc.v10.i13.4020]
Corresponding Author of This Article
Wei Xing, MD, Doctor, Department of Radiology, The Third Affiliated Hospital of Soochow University, No. 185 Juqian Street, Tianning District, Changzhou 213003, Jiangsu Province, China. suzhxingwei@suda.edu.cn
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Cohort Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. May 6, 2022; 10(13): 4020-4032 Published online May 6, 2022. doi: 10.12998/wjcc.v10.i13.4020
Table 1 MDCT scan parameters
Group
Scan protocol/parameters
Scan area
From diaphragm top to lower edge of symphysis pubis
Body position
Supine position
Tube voltage (kV)/tube current (mAs)
120/care dose 4D
Linear fusion coefficient
0.5
Pitch
1.0
Rotate speed
0.5 s
Collimation (mm)
2 × 192 × 0.6
Thickness of collection layer (mm)
1 mm
Interlayer spacing
0.6 mm
Convolution kernel
Br40
Enhancement protocol
Arterial phase (automatic tracking technology: when the aortic monitoring threshold reached 100 HU, the arterial phase scan was triggered); intravenous phase (scan started 75 s after the contrast agent was injected)
Contrast agent (concentration)
Iopromide (370 mgI/mL)
Dose and rate of contrast agent administration
1.5 mL/kg, 3.5 mL/s
Table 2 The demographic characteristics of death and survival groups
Total number (n = 53)
Survival group (n = 44)
Death group (n = 9)
P value
Sex (%)
0.938
Male
33 (62.3)
28 (52.8)
5 (9.4)
Female
20 (37.7)
16 (30.2)
4 (7.5)
Smoking (%)
1.000
No
35 (66.0)
29 (54.7)
6 (11.3)
Yes
18 (34.0)
15 (28.3)
3 (5.7)
Alcohol (%)
0.667
No
35 (66.0)
28 (52.8)
7 (13.2)
Yes
18 (34.0)
16 (30.2)
2 (3.8)
Diabetes (%)
0.978
No
44 (83.0)
36 (67.9)
8 (15.1)
Yes
9 (17.0)
8 (15.1)
1 (1.9)
Hypertension (%)
1.000
No
27 (50.9)
22 (41.5)
5 (9.4)
Yes
26 (49.1)
22 (41.5)
4 (7.5)
Heart disease (%)
1.000
No
26 (49.1)
22 (41.5)
4 (7.5)
Yes
27 (50.9)
22 (41.5)
5 (9.4)
Surgery (%)
0.395
No
38 (71.7)
30 (56.6)
8 (15.1)
Yes
15 (28.3)
14 (26.4)
1 (1.9)
Vomitus (%)
0.938
No
20 (37.7)
16 (30.2)
4 (7.5)
Yes
33 (62.3)
28 (52.8)
5 (9.4)
Age (yr)
74 (63.50, 80.50)
72 (62.25, 80.00)
75 (73.00, 82.00)
0.231
Abdominal pain duration (d)
1.00 (1.00, 5.00)
2.00 (1.00, 5.00)
1.00 (0.75, 2.00)
0.298
Body temperature at admission (℃)
36.7 (36.5, 37.7)
36.6 (36.4, 37.3)
37.7 (36.6, 38.4)
0.055
Table 3 Biochemical indicators of death and survival groups
Total number (n = 53)
Survival group (n = 44)
Death group (n = 9)
P value
D-dimer > 1000 μg/mL (%)
0.499
No
20 (37.7)
18 (34.0)
2 (3.8)
Yes
33 (62.3)
26 (49.1)
7 (13.2)
Blood lactate > 2.1 mmol/L (%)
0.004
No
44 (83.0)
40 (75.5)
4 (7.5)
Yes
9 (17.0)
4 (7.5)
5 (9.4)
Blood pH < 7.35 (%)
0.004
No
47 (88.7)
42 (79.2)
5 (9.4)
Yes
6 (11.3)
2 (3.8)
4 (7.5)
Blood amylase > 110 U/L (%)
0.027
No
32 (84.2)
29 (76.3)
3 (7.9)
Yes
6 (15.8)
3 (7.9)
3 (7.9)
Serum creatinine > 120 μmol/L (%)
0.097
No
36 (78.3)
32 (69.6)
4 (8.7)
Yes
10 (21.7)
6 (13.0)
4 (8.7)
White blood cell
10.6 (6.95, 15.45)
9.1 (6.73, 16.48)
10.7 (9.2, 14.6)
0.362
Red blood cell
4.19 (3.89, 4.64)
4.18 (3.97, 4.63)
4.48 (3.60, 4.94)
0.887
Neutrophil
8.5 (5.42, 13.66)
7.55 (5.36, 14.46)
9.42 (7.75, 12.90)
0.236
Lymphocyte
0.9 (0.6, 1.2)
0.90 (0.60, 1.20)
0.70 (0.55, 1.20)
0.392
Neutrophil/lymphocyte
9.3 (6.00, 16.22)
8.47 (5.48, 16.42)
13.46 (8.52, 17.33)
0.169
Total protein
64.4 (56.55, 70.85)
64.2 (56.73, 69.45)
67.0 (51.3, 76.05)
0.713
Albumin to total protein ratio
1.20 (1.0, 1.3)
1.20 (1.00, 1.38)
1.10 (1.00, 1.30)
0.516
Blood glucose
6.90 (5.65, 8.44)
6.8 (4.93, 8.44)
7.70 (6.90, 16.28)
0.107
Table 4 Comparison of multidetector computed tomography reading results of two radiologists
Total number
A
B
P value
Embolus involvement length (%)
≤ 20 mm
14
6
13
0.014
20-50 mm
11
10
11
1
≥ 50 mm
28
25
28
0.236
Embolus region (%)
I
5
4
5
1
II
1
1
1
1
III
2
0
2
0.024
IV
8
3
7
I + II
2
2
2
1
III + IV
19
18
19
1
I + II + III
1
1
1
1
II + III + IV
7
6
7
1
I + II + III + IV
8
8
8
1
Extravascular signs (%)
Decreased intestinal wall enhancement
30
24
28
0.255
Intestinal wall thinning
22
9
14
0.131
Intestinal wall thickening
14
14
14
1
Pneumatosis intestinalis
5
3
3
1
Infarction of the organs
22
18
22
0.108
Mesenteric fat stranding
29
25
27
0.67
Table 5 Comparison of multidetector computed tomography signs in death and survival groups
Survival group (n = 44)
Death group (n = 9)
P value
Embolus involvement length (%)
0.311
≤ 20 mm
12 (27.27)
1 (11.11)
20-50 mm
10 (22.73)
1 (11.11)
≥ 50 mm
22 (50.00)
7 (77.78)
Embolus region (%)
0.212
I
4 (9.09)
1 (11.11)
II
1 (2.27)
0 (0)
III
2 (4.55)
0 (0)
IV
8 (18.18)
0 (0)
I + II
1 (2.27)
1 (11.11)
III + IV
17 (38.64)
2 (22.22)
I + II + III
1 (2.27)
0 (0)
II + III + IV
6 (13.64)
1 (11.11)
I + II + III + IV
4 (9.09)
4 (44.44)
Decreased intestinal wall enhancement (%)
0.004
No
23 (52.27)
0 (0)
Yes
21 (47.73)
9 (100)
Intestinal wall thinning (%)
0.002
No
30 (68.18)
1 (11.11)
Yes
14 (31.82)
8 (88.89)
Intestinal wall thickening (%)
0.178
No
34 (77.27)
5 (55.56)
Yes
10 (22.73)
4 (44.44)
Pneumatosis intestinalis (%)
0.007
No
42 (95.45)
6 (66.67)
Yes
2 (4.55)
3 (33.33)
Infarction of other organs (%)
0.348
No
27 (61.36)
4 (44.44)
Yes
17 (38.64)
5 (55.56)
Mesenteric fat stranding (%)
0.127
No
22 (50)
2 (22.22)
Yes
22 (50)
7 (77.78)
Table 6 Univariate cox regression
HR
95%CI
P value
Intestinal wall thinking
2.27
(0.61-8.45)
0.223
Intestinal wall thinning
13.35
(1.54-99.01)
0.018
Pneumatosis intestinalis
5.73
(1.41-23.35)
0.015
Other organ infarction
1.79
(0.48-6.67)
0.386
mesenteric fat stranding
2.96
(0.62-14.27)
0.176
Blood lactate > 2.1 mmol/L
6.82
(1.82-25.60)
0.004
Blood pH < 7.35
7.36
(1.94-27.86)
0.003
Embolus distribution region (multi-classification variable)
Citation: Yang JS, Xu ZY, Chen FX, Wang MR, Cong RC, Fan XL, He BS, Xing W. Role of clinical data and multidetector computed tomography findings in acute superior mesenteric artery embolism. World J Clin Cases 2022; 10(13): 4020-4032